FLT3 mutations lead to abnormal activation of the FLT3 receptor, which continuously activates downstream signaling pathways such as Ras/MAPK/, STAT5, PI3K/Akt/mTOR, inhibits cell apoptosis, and promotes the proliferation and survival of leukemia cells [36]. Here, FLT3 is linked to leukemia.